JOHN OSEI TUTU: Open Payments
NPI 1912042169 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 24 payments from 7 companies in 2025. Trend: 2023 $229 · 2024 $535 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $133 |
| E.R. Squibb & Sons, L.L.C. | 5 | $129 |
| Alkermes, Inc. | 5 | $126 |
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| Lundbeck LLC | 3 | $52 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: COBENFY, UZEDY, ABILIFY MAINTENA, ARISTADA, REXULTI, INVEGA SUSTENNA, VIVITROL, LYBALVI.
Industry payments across NY — which companies pay providers there.
